TrialOpen forum infectious diseases2025

Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series.

Félix Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.